News

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.
Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.
Almost 100,000 patients were waiting for routine treatment at King's College Hospital in February, new figures show.